Table 2. TAH-t support details in CHD and non-CHD patients.
| Variables | TAH-t with CHD (n=80) | TAH-t with non-CHD (n=1,796) | P value |
|---|---|---|---|
| TAH-t patient data, n (%) | |||
| 50 cc TAH-t | 9 (11.3) | 80 (4.5) | 0.005 |
| 70 cc TAH-t | 71 (88.8) | 1,716 (95.9) | 0.002 |
| Duration of TAH-t support | n=80 | n=1,789 | |
| Total days (all patients, years) | 11,554 (31.6) | 243,441 (667.0) | N/A |
| Average ± SD (days) | 145±222 | 136±212 | 0.711 |
| Duration, n (%) | n=80 | n=1,789 | |
| 0–6 months | 60 (75.0) | 1,393 (77.9) | 0.547 |
| 6–12 months | 12 (15.0) | 220 (12.3) | 0.473 |
| 12–24 months | 5 (6.3) | 128 (7.2) | 0.758 |
| >24 months | 3 (3.8) | 48 (2.7) | 0.567 |
Percentages based on number of patients in each group with available data for given variable as indicated by n=xx listed in same row as variable name.